321 related articles for article (PubMed ID: 33386004)
21. Relationship between tumor cell infiltration and 5-aminolevulinic acid fluorescence signals after resection of MR-enhancing lesions and its prognostic significance in glioblastoma.
Kim J-; Jung T-; Jung S; Kim I-; Jang W-; Moon K-; Kim S-; Kim J-; Lee K-
Clin Transl Oncol; 2021 Mar; 23(3):459-467. PubMed ID: 32617871
[TBL] [Abstract][Full Text] [Related]
22. Fluorescein Sodium in the Surgical Treatment of Recurrent Glioblastoma Multiforme.
Höhne J; Schebesch KM; de Laurentis C; Akçakaya MO; Pedersen CB; Brawanski A; Poulsen FR; Kiris T; Cavallo C; Broggi M; Ferroli P; Acerbi F
World Neurosurg; 2019 May; 125():e158-e164. PubMed ID: 30682505
[TBL] [Abstract][Full Text] [Related]
23. Supratotal Resection of Glioblastoma: Is Less More?
Altieri R; Melcarne A; Soffietti R; Rudá R; Franchino F; Pellerino A; La Rocca G; Sabatino G; Olivi A; Ducati A; Zeppa P; Tardivo V; Mantovani C; Chiovatero I; Martini S; Dolce P; Savastano R; Lanotte MM; Zenga F; Garbossa D
Surg Technol Int; 2019 Nov; 35():432-440. PubMed ID: 31373379
[TBL] [Abstract][Full Text] [Related]
24. 5-Aminolevulinic Acid and Contrast-Enhanced Ultrasound: The Combination of the Two Techniques to Optimize the Extent of Resection in Glioblastoma Surgery.
Della Pepa GM; Ius T; La Rocca G; Gaudino S; Isola M; Pignotti F; Rapisarda A; Mazzucchi E; Giordano C; Dragonetti V; Chiesa S; Balducci M; Gessi M; Skrap M; Olivi A; Marchese E; Sabatino G
Neurosurgery; 2020 Jun; 86(6):E529-E540. PubMed ID: 32186345
[TBL] [Abstract][Full Text] [Related]
25. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
[TBL] [Abstract][Full Text] [Related]
26. Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery.
Cordova JS; Gurbani SS; Holder CA; Olson JJ; Schreibmann E; Shi R; Guo Y; Shu HK; Shim H; Hadjipanayis CG
Mol Imaging Biol; 2016 Jun; 18(3):454-62. PubMed ID: 26463215
[TBL] [Abstract][Full Text] [Related]
27. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
28. FLAIRectomy in Supramarginal Resection of Glioblastoma Correlates With Clinical Outcome and Survival Analysis: A Prospective, Single Institution, Case Series.
Certo F; Altieri R; Maione M; Schonauer C; Sortino G; Fiumanò G; Tirrò E; Massimino M; Broggi G; Vigneri P; Magro G; Visocchi M; Barbagallo GMV
Oper Neurosurg (Hagerstown); 2021 Jan; 20(2):151-163. PubMed ID: 33035343
[TBL] [Abstract][Full Text] [Related]
29. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L
J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368
[TBL] [Abstract][Full Text] [Related]
30. Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery.
Roessler K; Becherer A; Donat M; Cejna M; Zachenhofer I
Neurol Res; 2012 Apr; 34(3):314-7. PubMed ID: 22449387
[TBL] [Abstract][Full Text] [Related]
31. Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping.
Schucht P; Beck J; Abu-Isa J; Andereggen L; Murek M; Seidel K; Stieglitz L; Raabe A
Neurosurgery; 2012 Nov; 71(5):927-35; discussion 935-6. PubMed ID: 22895402
[TBL] [Abstract][Full Text] [Related]
32. Dual-Use Intraoperative MRI in Glioblastoma Surgery: Results of Resection, Histopathologic Assessment, and Surgical Site Infections.
Wach J; Goetz C; Shareghi K; Scholz T; Heßelmann V; Mager AK; Gottschalk J; Vatter H; Kremer P
J Neurol Surg A Cent Eur Neurosurg; 2019 Nov; 80(6):413-422. PubMed ID: 31272122
[TBL] [Abstract][Full Text] [Related]
33. From white to blue light: evolution of endoscope-assisted intracranial tumor neurosurgery and expansion to intraaxial tumors.
Ruzevick J; Cardinal T; Pangal DJ; Bove I; Strickland B; Zada G
J Neurosurg; 2023 Jul; 139(1):59-64. PubMed ID: 36681992
[TBL] [Abstract][Full Text] [Related]
34. Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections.
Heßelmann V; Mager AK; Goetz C; Detsch O; Theisgen HK; Friese M; Schwindt W; Gottschalk J; Kremer P
Rofo; 2017 Jun; 189(6):519-526. PubMed ID: 28591887
[No Abstract] [Full Text] [Related]
35. Extent of resection affects prognosis for patients with glioblastoma in non-eloquent regions.
Kow CY; Kim BJH; Park TI; Chen JCC; Vong CK; Kim JY; Shim V; Dragunow M; Heppner P
J Clin Neurosci; 2020 Oct; 80():242-249. PubMed ID: 33099354
[TBL] [Abstract][Full Text] [Related]
36. Effects of 5-ALA dose on resection of glioblastoma.
Michael AP; Watson VL; Ryan D; Delfino KR; Bekker SV; Cozzens JW
J Neurooncol; 2019 Feb; 141(3):523-531. PubMed ID: 30644009
[TBL] [Abstract][Full Text] [Related]
37. Impact of removed tumor volume and location on patient outcome in glioblastoma.
Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
[TBL] [Abstract][Full Text] [Related]
38. Which Parameter Is More Important for the Prognosis of New-Onset Adult Glioblastoma: Residual Tumor Volume or Extent of Resection?
Xing Y; Wang X
World Neurosurg; 2018 Aug; 116():e444-e451. PubMed ID: 29753893
[TBL] [Abstract][Full Text] [Related]
39. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
[TBL] [Abstract][Full Text] [Related]
40. Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection.
Prada F; Bene MD; Fornaro R; Vetrano IG; Martegani A; Aiani L; Sconfienza LM; Mauri G; Solbiati L; Pollo B; DiMeco F
Neurosurg Focus; 2016 Mar; 40(3):E7. PubMed ID: 26926065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
